Tonix adds second Medicare payer deal for fibromyalgia drug Tonmya

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Tonix adds second Medicare payer deal for fibromyalgia drug Tonmya

Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®

September 22, 2026 7:00 AM EDT

New agreement, effective immediately, adds approximately 21 million Medicare lives (38% of approximately 55 million Medicare lives in the U.S.)

Commercial and government payer coverage for TONMYA now reaches approximately 166 million covered lives (53% of total U.S. lives)

BERKELEY HEIGHTS, N.J., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully integrated, commercial-stage biopharmaceutical company, today announced a second major managed Medicare agreement for TONMYA® (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults that is effective immediately, adding approximately 21... More